Experienced in Neuroendocrine Tumor

Dr. Elizabeth Schorry

Medical Genetics | Pediatrics
Children's Hospital Medical Center
3333 Burnet Ave, Ml 5021, 
Cincinnati, OH 
Experienced in Neuroendocrine Tumor
Children's Hospital Medical Center
3333 Burnet Ave, Ml 5021, 
Cincinnati, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Elizabeth Schorry is a Medical Genetics specialist and a Pediatrics provider in Cincinnati, Ohio. Dr. Schorry is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Neurofibromatosis, Neurofibromatosis Type 1 (NF1), Brittle Cornea Syndrome, and Vascular Ehlers-Danlos Syndrome (VEDS).

Her clinical research consists of co-authoring 44 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 5 articles and participated in 1 clinical trial in the study of Neuroendocrine Tumor.

Specialties
Medical Genetics
Pediatrics
Licenses
Clinical Genetics in OH
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medical Health
  • HMO
  • PPO

Locations

CHILDREN'S HOSPITAL MEDICAL CENTER
3333 Burnet Ave, Ml 5021, Cincinnati, OH 45229

Additional Areas of Focus

Dr. Schorry has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase II Study of Binimetinib in Children and Adults With NF1 Associated Plexiform Neurofibromas (PNOC010)
A Phase II Study of Binimetinib in Children and Adults With NF1 Associated Plexiform Neurofibromas (PNOC010)
Enrollment Status: Completed
Publish Date: May 02, 2025
Intervention Type: Drug
Study Drug: Binimetinib
Study Phase: Phase 2
A Phase II Study of Cabozantinib (XL184) for Plexiform Neurofibromas in Subjects With Neurofibromatosis Type 1 in Children and Adults
A Phase II Study of Cabozantinib (XL184) for Plexiform Neurofibromas in Subjects With Neurofibromatosis Type 1 in Children and Adults
Enrollment Status: Completed
Publish Date: May 24, 2023
Intervention Type: Drug
Study Drug: Cabozantinib
Study Phase: Phase 2
A Phase II Trial on the Effect of Low-Dose Versus High-Dose Vitamin D Supplementation on Bone Mass in Adults With Neurofibromatosis Type 1 (NF1)
A Phase II Trial on the Effect of Low-Dose Versus High-Dose Vitamin D Supplementation on Bone Mass in Adults With Neurofibromatosis Type 1 (NF1)
Enrollment Status: Terminated
Publish Date: May 25, 2022
Intervention Type: Drug
Study Drug: Cholecalciferol
Study Phase: Phase 2
A Study of INFUSE Bone Graft (Recombinant Human Bone Morphogenetic Protein-2/Absorbable Collagen Sponge) in the Treatment of Tibial Pseudarthrosis in Neurofibromatosis 1 (NF1)
A Study of INFUSE Bone Graft (Recombinant Human Bone Morphogenetic Protein-2/Absorbable Collagen Sponge) in the Treatment of Tibial Pseudarthrosis in Neurofibromatosis 1 (NF1)
Enrollment Status: Terminated
Publish Date: October 27, 2021
Intervention Type: Procedure, Device
Study Phase: Not Applicable
Open-label, Phase 2 Study of Bevacizumab in Children and Young Adults With Neurofibromatosis 2 and Progressive Vestibular Schwannomas That Are Poor Candidates for Standard Treatment With Surgery or Radiation
Open-label, Phase 2 Study of Bevacizumab in Children and Young Adults With Neurofibromatosis 2 and Progressive Vestibular Schwannomas That Are Poor Candidates for Standard Treatment With Surgery or Radiation
Enrollment Status: Completed
Publish Date: February 12, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

44 Total Publications

Qualitative aspects of pain in children and adults with neurofibromatosis type 1 and plexiform neurofibromas: Causes, consequences, and communication.
Qualitative aspects of pain in children and adults with neurofibromatosis type 1 and plexiform neurofibromas: Causes, consequences, and communication.
Journal: Journal of health psychology
Published: July 13, 2025
Similar Doctors
Advanced in Neuroendocrine Tumor
Dr. Janee L. Bey
Hospital Medicine | Pediatrics
Advanced in Neuroendocrine Tumor
Dr. Janee L. Bey
Hospital Medicine | Pediatrics

Trihealth H LLC

379 Dixmyth Ave, 
Cincinnati, OH 
 (1.1 miles away)
513-246-7000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Janee Bey is a Hospital Medicine specialist and a Pediatrics provider in Cincinnati, Ohio. Dr. Bey is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Neuroendocrine Tumor, Liver Failure, Gastrointestinal Bleeding, Endoscopy, and Ureteroscopy. Dr. Bey is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Schorry's expertise for a condition
ConditionClose
    View All 21 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile